ARID1A and neoplasm: While key driver genes such as TP53, CDH1, and ARID1A were again common to both tumor regions, six out of nine PDOs showed subclonal mutations, including mutations in genes such as APC and BRCA2, that were only present in one of the two analyzed regional PDOs.